AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2022
Jan 11, 2022
32300_dirs_2022-01-11_9e2d1952-f353-4d51-911b-5207264fa5ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2022-01-11
Reporting Person: SLAYEN HOWARD T (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-11 | Common Stock | M | 17247 | $2.1000 | Acquired | 210762 | Direct |
| 2022-01-11 | Common Stock | M | 10000 | $2.1700 | Acquired | 220762 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-11 | Non-Qualified Stock Option (right to buy) | $2.1000 | M | 17247 | Disposed | 2022-04-21 | Common Stock (17247) | Direct |
| 2022-01-11 | Non-Qualified Stock Option (right to buy) | $2.1700 | M | 10000 | Disposed | 2022-10-20 | Common Stock (10000) | Direct |
Footnotes
F1: The amount reported includes shares subject to unvested restricted stock units.
F2: One sixth (1/6) of the total number of shares became exercisable on this date and an additional one sixth (1/6) of the total number of shares became exercisable each month thereafter.
F3: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.
More from AEHR TEST SYSTEMS
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4